Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2319 (LINC02319) is classified as a long non-coding RNA, specifically a long intergenic non-coding RNA (lincRNA), meaning it is transcribed from genomic regions that do not overlap with protein-coding genes[1][7]. LINC02319 is annotated in human genomic databases, but there is no functional or disease association described in gene function compendia to date. LINC02319 is not recognized as a canonical therapeutic target such as a receptor, enzyme, or transporter, and there is no research to suggest it is implicated in disease mechanisms or clinical pharmacology[1]. If structured information or new findings about its function or disease links become available, further updates could be necessary.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2319 (LINC02319).